Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of the trial is to investigate the efficacy and
safety of liraglutide versus lixisenatide as add-on to metformin in subjects with type 2
diabetes (T2DM).